We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
(+7.2%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
8.12%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,821
Reduced
816
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$89.1M |
| 2 |
WEX
WEX
|
+$78.4M |
| 3 |
Blackrock
BLK
|
+$73.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$71.9M |
| 5 |
OneMain Financial
OMF
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$63.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$56.6M |
| 3 |
Agnico Eagle Mines
AEM
|
+$55.1M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$36M |
| 5 |
ORBC
ORBCOMM, Inc.
ORBC
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.39% |
| 2 | Financials | 14.65% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
10x Genomics
TXG
$6.61B
| $629K | ﹤0.01% |
4,328
-14,837
| -77% | -$2.55M |
|
1177
Brown & Brown
BRO
$23.9B
| $628K | ﹤0.01% |
11,331
+10,821
| +2,122% | +$603K |
|
1178
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.84B
| $627K | ﹤0.01% |
20,933
-2,116
| -9% | -$65.2K |
|
1179
Stellus Capital Investment Corp
SCM
$243M
| $624K | ﹤0.01% |
47,851
+1,021
| +2% | +$13.4K |
|
|
DMC
1180
Del Monte Corp
DMC
$1.45B
| $623K | ﹤0.01% |
19,350
| – | – |
|
1181
First Trust Indxx NextG ETF
NXTG
$564M
| $623K | ﹤0.01% |
8,175
+2,107
| +35% | +$163K |
|
1182
BlackLine
BL
$1.72B
| $622K | ﹤0.01% |
5,273
-873
| -14% | -$100K |
|
1183
Invesco
IVZ
$13.9B
| $620K | ﹤0.01% |
25,736
+1,241
| +5% | +$31K |
|
|
NID
1184
DELISTED
NUVEEN INTERMEDIATE DURATION MUNICIPAL TERM FUND
NID
| $620K | ﹤0.01% |
42,168
+27,808
| +194% | +$413K |
|
1185
JD.com
JD
$44.5B
| $618K | ﹤0.01% |
8,557
-20,877
| -71% | -$1.54M |
|
1186
Fastenal
FAST
$59.5B
| $614K | ﹤0.01% |
23,836
-932
| -4% | -$25.3K |
|
1187
Pacer Developed Markets International Cash Cows 100 ETF
ICOW
$1.87B
| $614K | ﹤0.01% |
19,778
+5,082
| +35% | +$164K |
|
1188
iShares MSCI Canada ETF
EWC
$6.33B
| $613K | ﹤0.01% |
16,922
+1,526
| +10% | +$56.6K |
|
1189
AES
AES
$10.5B
| $612K | ﹤0.01% |
26,865
+965
| +4% | +$23.4K |
|
1190
Knight Transportation
KNX
$11.4B
| $609K | ﹤0.01% |
11,925
+9,475
| +387% | +$477K |
|
|
MIC
1191
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $608K | ﹤0.01% |
15,000
| – | – |
|
1192
Invesco S&P MidCap Quality ETF
XMHQ
$5.63B
| $607K | ﹤0.01% |
8,000
| – | – |
|
1193
State Street SPDR S&P Transportation ETF
XTN
$399M
| $598K | ﹤0.01% |
6,919
-4,010
| -37% | -$340K |
|
|
HTO
1194
H2O America
HTO
$2.62B
| $597K | ﹤0.01% |
9,045
+3,591
| +66% | +$242K |
|
1195
Genmab
GMAB
$19.5B
| $596K | ﹤0.01% |
13,651
+2,493
| +22% | +$112K |
|
1196
Roblox
RBLX
$27B
| $596K | ﹤0.01% |
7,899
+5,915
| +298% | +$486K |
|
1197
Core Alternative Capital
CCOR
$28M
| $593K | ﹤0.01% |
20,026
+17,669
| +750% | +$531K |
|
|
MCW
1198
DELISTED
Mister Car Wash
MCW
| $591K | ﹤0.01% |
32,385
+4,517
| +16% | +$89.6K |
|
1199
Ulta Beauty
ULTA
$24.3B
| $591K | ﹤0.01% |
1,640
+270
| +20% | +$97.5K |
|
1200
Northern Trust
NTRS
$33.9B
| $587K | ﹤0.01% |
5,461
+50
| +0.9% | +$5.68K |
|
Similar funds
NAMI
Rockefeller Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,821 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.
- Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
- Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
- Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
- Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
- Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
- Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
- Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.
Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.